XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Statement of Comprehensive Income [Abstract]        
Revenue $ 1,607 $ 1,027 $ 3,758 $ 2,657
Operating expenses:        
Cost of goods sold (exclusive of depreciation and amortization) 2,585 3,232 8,270 9,397
Research and development 3,545 5,007 12,325 14,579
Selling, general and administrative 8,016 6,152 24,570 18,722
Depreciation and amortization 1,313 1,256 3,926 3,559
Total operating expenses 15,459 15,647 49,091 46,257
Operating loss (13,852) (14,620) (45,333) (43,600)
Other income (expense):        
Interest expense, net (2,217) (1,740) (6,706) (1,614)
Change in fair value of warrants 2,143 (6,737) (19,523) (9,800)
Other income (loss), net 343 (99) 2,091 (166)
Loss before income taxes (13,583) (23,196) (69,471) (55,180)
Provision for income taxes 26 24 138 159
Net loss (13,609) (23,220) (69,609) (55,339)
Foreign currency translation adjustment 1,005 (670) 304 (218)
Comprehensive loss (12,604) (23,890) (69,305) (55,557)
Net loss (13,609) (23,220) (69,609) (55,339)
Net loss attributable to common stockholders $ (13,609) $ (23,220) $ (69,609) $ (55,339)
Weighted average of shares outstanding – basic (in shares) 126,429 108,045 118,978 107,504
Weighted average of shares outstanding – diluted (in shares) 126,429 108,045 118,978 107,504
Net loss attributable to common stockholders per share - basic (in dollars per share) $ (0.11) $ (0.21) $ (0.59) $ (0.51)
Net loss attributable to common stockholders per share - diluted (in dollars per share) $ (0.11) $ (0.21) $ (0.59) $ (0.51)